Zacks Small Cap Research on MSN32m
RVPH: Year-End OLE UpdateRVPH READ THE FULL RVPH RESEARCH REPORT Operational and Financial Results On November 14th, 2024, Reviva Pharmaceutical ...
Sage Therapeutics has been working in the area of steroid-derived compounds that affect CNS receptor signaling.
No approved drug in the U.S. has been able to fully address these symptoms. While second generation antipsychotics offer benefits, negative symptoms remain a major unmet need to provide comprehensive ...
Elite Pharmaceuticals ( (ELTP) ) has provided an update.
As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.
The FDA has granted fast-track approval for a groundbreaking gene therapy indicated for a rare genetic disorder called aromatic L-amino acid decarboxylase (AADC) deficiency.
Hello, Reader. For all that artificial intelligence has accomplished over the last few years, one thing it has not yet ...
Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...
The U.S. Supreme Court turned away on Monday a bid by Alvogen's subsidiary Norwich Pharmaceuticals to sell a generic version ...
The U.S. patient population for Revuforj in its approved indication is roughly 2,000 according to Syndax. KMT2A leukemias ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback